Advanced Glycation End Products Induce Human Corneal Epithelial Cells Apoptosis through Generation of Reactive Oxygen Species and Activation of JNK and p38 MAPK Pathways

被引:88
作者
Shi, Long [1 ,2 ,3 ]
Yu, Xiaoming [1 ,2 ,3 ]
Yang, Hongling [1 ]
Wu, Xinyi [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China
[2] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China
[3] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Peoples R China
关键词
N-EPSILON-CARBOXYMETHYLLYSINE; OXIDATIVE STRESS; NADPH OXIDASE; IN-VITRO; RECEPTOR; RAGE; EXPRESSION; AGES; MECHANISMS; DISEASE;
D O I
10.1371/journal.pone.0066781
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Advanced Glycation End Products (AGEs) has been implicated in the progression of diabetic keratopathy. However, details regarding their function are not well understood. In the present study, we investigated the effects of intracellular reactive oxygen species (ROS) and JNK, p38 MAPK on AGE-modified bovine serum albumin (BSA) induced Human telomerase-immortalized corneal epithelial cells (HUCLs) apoptosis. We found that AGE-BSA induced HUCLs apoptosis and increased Bax protein expression, decreased Bcl-2 protein expression. AGE-BSA also induced the expression of receptor for advanced glycation end product (RAGE). AGE-BSA-RAGE interaction induced intracellular ROS generation through activated NADPH oxidase and increased the phosphorylation of p47phox. AGE-BSA induced HUCLs apoptosis was inhibited by pretreatment with NADPH oxidase inhibitors, ROS quencher N-acetylcysteine (NAC) or neutralizing anti-RAGE antibodies. We also found that AGE-BSA induced JNK and p38 MAPK phosphorylation. JNK and p38 MAPK inhibitor effectively blocked AGE-BSA-induced HUCLs apoptosis. In addition, NAC completely blocked phosphorylation of JNK and p38 MAPK induced by AGE-BSA. Our results indicate that AGE-BSA induced HUCLs apoptosis through generation of intracellular ROS and activation of JNK and p38 MAPK pathways.
引用
收藏
页数:10
相关论文
共 57 条
[1]   TGFβ1 induces apoptosis in invasive prostate cancer and bladder cancer cells via Akt-independent, p38 MAPK and JNK/SAPK-mediated activation of caspases [J].
Al-Azayzih, Ahmad ;
Gao, Fei ;
Goc, Anna ;
Somanath, Payaningal R. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 427 (01) :165-170
[2]   Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor [J].
Alikhani, Mani ;
MacLellan, Christine M. ;
Raptis, Markos ;
Vora, Siddarth ;
Trackman, Philip C. ;
Graves, Dana T. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 292 (02) :C850-C856
[3]   Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways [J].
Alikhani, Mani ;
Alikhani, Zoubin ;
Boyd, Coy ;
MacLellan, Christine M. ;
Raptis, Markos ;
Liu, Rongkun ;
Pischon, Nicole ;
Trackman, Philip C. ;
Gerstenfeld, Louis ;
Graves, Dana T. .
BONE, 2007, 40 (02) :345-353
[4]   Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats [J].
Alves, M ;
Calegari, VC ;
Cunha, DA ;
Saad, MJA ;
Velloso, LA ;
Rocha, EM .
DIABETOLOGIA, 2005, 48 (12) :2675-2681
[5]   RAGE biology, atherosclerosis and diabetes [J].
Barlovic, Drazenka Pongrac ;
Soro-Paavonen, Aino ;
Jandeleit-Dahm, Karin A. M. .
CLINICAL SCIENCE, 2011, 121 (1-2) :43-55
[6]   At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products [J].
Basta, G ;
Lazzerini, G ;
Del Turco, S ;
Ratto, GM ;
Schmidt, AM ;
De Caterina, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (07) :1401-1407
[7]  
Belambri SA, 2012, AM J BLOOD RES, V2, P187
[8]   Serum levels of the advanced glycation end products Nε-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension [J].
Busch, Martin ;
Franke, Sybille ;
Wolf, Gunter ;
Rohde, Richard D. ;
Stein, Guenter .
NEPHRON CLINICAL PRACTICE, 2008, 108 (04) :C291-C297
[9]   The advanced glycation end product Nε-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension [J].
Busch, Martin ;
Franke, Sybille ;
Wolf, Gunter ;
Brandstaedt, Antje ;
Ott, Undine ;
Gerth, Jens ;
Hunsicker, Lawrence G. ;
Stein, Guenter .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (04) :571-579
[10]   Genome-Wide Identification and Analysis of MAPK and MAPKK Gene Families in Brachypodium distachyon [J].
Chen, Lihong ;
Hu, Wei ;
Tan, Shenglong ;
Wang, Min ;
Ma, Zhanbing ;
Zhou, Shiyi ;
Deng, Xiaomin ;
Zhang, Yang ;
Huang, Chao ;
Yang, Guangxiao ;
He, Guangyuan .
PLOS ONE, 2012, 7 (10)